Clinuvel Pharmaceuticals Upgrades U.S. Listing to Nasdaq
Clinuvel Pharmaceuticals has upgraded its U.S. listing to the Nasdaq Stock Market under the ticker symbol 'CUVL'. The move follows regulatory approval on July 17 and is expected to enhance visibility for the company's American Depositary Shares (ADS). This transition could improve liquidity and attract broader investor interest.
Topics: adshares nasdaq stock listing